World Health Organization guidance states that medicines intended to reduce body weight should not be used routinely in children younger than ten. The document emphasizes that clinical care for young children should concentrate on promoting healthy eating and regular physical activity rather than relying on pharmacological options, explicitly citing medicines such as weight‑loss injections as unsuitable for this age group.
The recommendations place non‑pharmacological approaches at the centre of management for young children with excess weight. Care pathways described in the guidance highlight the role of family‑centred support and behaviour‑based interventions aimed at improving dietary patterns and increasing physical activity, tailored to the child’s developmental needs and household context. Health professionals are encouraged to consider these measures as first‑line options before any discussion of medication.
For clinicians and health services, the guidance provides a framework for decision‑making around treatment options for young patients. It signals that prescriptions of weight‑loss medicines for children under ten should be exceptional and carefully justified. Parents and caregivers are advised to seek advice from qualified health professionals about safe, age‑appropriate strategies to support a child’s healthy growth rather than pursuing pharmacological solutions.
The guidance also carries implications for national health policy and practice: public health programmes, primary care providers and paediatric services will need to align local protocols with the recommendations and reinforce preventive measures. As attention to childhood obesity and its consequences continues, the document aims to refocus interventions on lifestyle and family support for children, leaving decisions about medicines for older age groups to clinical judgement framed by broader regulatory and ethical considerations.
